The Latin America flow cytometry market was valued at USD 293.8 million in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 5.9% between 2025 and 2030. This growth is largely driven by increasing research and development (R&D) activities across clinical, biotechnology, and life sciences sectors. Technological advancements in reagents and instruments, rising demand for point-of-care diagnostics, and the growing prevalence of infectious and chronic diseases also contribute significantly to the market expansion.

Globally, cancer remains a major concern, with around 20 million new cases and 9.7 million deaths recorded in 2022, figures projected to increase to nearly 30 million new cases and over 15 million deaths. This surge in chronic disease prevalence is fueling life sciences research aimed at developing improved diagnostic and therapeutic solutions, thereby boosting the flow cytometry market.

Further supporting market growth is the increase in investments and funding toward biotechnology, clinical, biopharmaceutical, and life sciences research, which enhances R&D efforts in cell analysis for drug discovery and development using flow cytometry techniques. Advances in instrumentation have enhanced the precision, efficiency, and affordability of flow cytometry systems, opening new growth opportunities.

Additionally, data from the Pan American Health Organization (PAHO) reveals a 9% increase in new HIV infections in Latin America between 2010 and 2023, with approximately 120,000 new cases reported in 2023 alone. Rising awareness and the emphasis on early diagnosis have driven demand for point-of-care diagnostics for HIV and other sexually transmitted infections, further propelling the market demand in the region.

Key Market Trends & Insights:

• By product category, the instrument segment held the largest portion of the market, capturing a market share of 34.9% in 2024. This indicates that the demand for flow cytometry instruments, such as analyzers and sorters, is the strongest among product offerings in the Latin America market.

• When analyzed by technology, the cell-based flow cytometry segment dominated the market in 2024, reflecting its widespread use in various research and clinical applications due to its ability to analyze and sort individual cells with high precision.

• In terms of application, the clinical segment led the market in 2024, highlighting the extensive use of flow cytometry in clinical diagnostics, disease monitoring, and therapeutic development, particularly for conditions such as cancer and infectious diseases.

• Regarding end-use, academic institutes accounted for the largest market share in 2024, showcasing their significant role in driving research activities, development, and adoption of flow cytometry technologies across Latin America.

Order a free sample PDF of the Latin America Flow Cytometry Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2024 Market Size: USD 293.8 Million

• 2030 Projected Market Size: USD 420.5 Million

• CAGR (2025-2030): 5.9%

Key Companies & Market Share Insights:

Several prominent companies play a significant role in the Latin America flow cytometry market, including Cytiva, Sartorius AG, BD, Agilent Technologies, Inc., Sysmex Corporation, among others. These market leaders are actively pursuing a variety of strategic approaches, such as developing and launching cutting-edge products, engaging in mergers and acquisitions, and investing in research initiatives to strengthen their market positions and gain a competitive advantage.

BD, a global medical technology firm, operates across multiple healthcare sectors, including medication management, infection prevention, and diagnostics. The company offers an extensive portfolio of flow cytometry products, including instruments, reagents, and software designed for both research and clinical applications. One notable product is the BD FACSDuet Sample Preparation System, which supports efficient sample processing.

Cytiva, operating within the life sciences industry, delivers products and services aimed at advancing cell and gene therapy, protein research, and bioprocessing. The company also provides innovative flow cytometry solutions tailored for research and clinical diagnostics, including products like Flow Cells, which enhance analytical capabilities in these fields.

Key Players

• Cytiva

• Sartorius AG

• BD

• Agilent Technologies, Inc.

• Sysmex Corporation

• Apogee Flow Systems Ltd.

• Thermo Fisher Scientific Inc.

• Bio-Rad Laboratories, Inc.

• Cytek

• Miltenyi Biotec.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The Latin America flow cytometry market is experiencing steady growth, driven by increased research and development activities in clinical, biotechnology, and life sciences sectors. Technological advancements in reagents and instruments, along with a rising demand for point-of-care diagnostics, are further propelling market expansion. The growing prevalence of infectious and chronic diseases, such as cancer and HIV, has heightened the need for precise diagnostic tools, thereby boosting the adoption of flow cytometry techniques. Investments and financing in biotechnology and clinical research are strengthening R&D efforts, leading to innovations in cell analysis for drug discovery and development.